CIBC Private Wealth Group LLC

Position in ASND — Ascendis Pharma A/S

CIK 1298088 ATLANTA, GA

Position in ASND

as of Dec 31, 2025 · filed Feb 12, 2026 Compact

Position Value

$2,000,617

+$334,987 QoQ

Shares Held

9,382

+12.0% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Dec 31, 2025

CIBC Private Wealth Group LLC holds $101,906,850 across 130 Biotechnology names. ASND ranks #5 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	200,425	$79,699,001
2	VRTX	Vertex Pharmaceuticals Inc / Ma	7,087	$3,212,962
3	AXSM	Axsome Therapeutics, Inc.	15,684	$2,864,525
4	LXRX	Lexicon Pharmaceuticals, Inc.	1,950,000	$2,242,500
5	ASND	Ascendis Pharma A/S This page	9,382	$2,000,617
6	REGN	Regeneron Pharmaceuticals, Inc.	1,943	$1,499,743
7	PGEN	Precigen, Inc.	274,712	$1,148,296
8	MRVI	Maravai Lifesciences Holdings, Inc.	279,224	$907,478

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$2,000,617	9,382	+12.0%	Shares	Sole	2026-02-12
2025-09-30	$1,665,630	8,378	0.0%	Shares	Sole	2025-11-24
2025-06-30	$1,446,042	8,378	0.0%	Shares	Sole	2025-08-12
2025-03-31	$1,305,795	8,378	0.0%	Shares	Sole	2025-05-14
2024-12-31	$1,153,399	8,378	0.0%	Shares	Sole	2025-02-12
2024-09-30	$1,250,919	8,378	0.0%	Shares	Sole	2024-11-13
2024-06-30	$1,142,591	8,378	0.0%	Shares	Sole	2024-08-09
2024-03-31	$1,266,502	8,378	+47.8%	Shares	Sole	2024-05-10
2023-12-31	$713,884	5,668	—	Shares	Defined	2024-02-13
No filing history on record for this holder in this stock.